- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 546354, 7 pages
Prevalence and Genetic Variability in Capsid L1 Gene of Rare Human Papillomaviruses (HPV) Found in Cervical Lesions of Women from North-East Brazil
1Department of Genetics, Federal University of Pernambuco, Brazil
2Gynaecological Unit, University Hospital Oswaldo Cruz, Brazil
3Gynaecological Unit, Integrated Medicine Center, Brazil
4Department of Histology and Embryology, Federal University of Pernambuco, Brazil
5Molecular Biology Laboratory, Pediatric Oncohematology Center, University of Pernambuco, Brazil
6Cidade Universitária, 50670-901, Recife, PE, Brazil
Received 20 February 2013; Revised 30 April 2013; Accepted 9 May 2013
Academic Editor: Franco Roperto
Copyright © 2013 Ana Pavla Almeida Diniz Gurgel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011.
- A. C. De Freitas, “Vaccine strategies against human papillomavirus: a discussion focused on developing countries,” Journal of Clinical & Cellular Immunology, vol. 1, no. S4, 2012.
- H. Zur Hausen, “Papillomavirus infections—a major cause of human cancers,” Biochimica et Biophysica Acta, vol. 1288, no. 2, pp. F55–F78, 1996.
- A. C. De Freitas, A. P. A. D. Gurgel, B. S. Chagas, E. C. Coimbra, and C. M. M. Do Amaral, “Susceptibility to cervical cancer: an overview,” Gynecologic Oncology, vol. 126, no. 2, pp. 304–311, 2012.
- H. U. Bernard, R. D. Burk, Z. Chen, K. van Doorslaer, H. Z. Hausen, and E. M. de Villiers, “Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments,” Virology, vol. 401, no. 1, pp. 70–79, 2010.
- E. M. De Villiers, C. Fauquet, T. R. Broker, H. U. Bernard, and H. Zur Hausen, “Classification of papillomaviruses,” Virology, vol. 324, no. 1, pp. 17–27, 2004.
- H. Zur Hausen, “Papillomaviruses and cancer: from basic studies to clinical application,” Nature Review Cancer, vol. 2, no. 5, pp. 342–350, 2002.
- M. Schiffman, G. Clifford, and F. M. Buonaguro, “Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline,” Infectious Agents and Cancer, vol. 4, no. 1, article 8, 2009.
- S. de Sanjose, W. G. V. Quint, L. Alemany et al., “Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study,” The Lancet Oncology, vol. 11, no. 11, pp. 1048–1056, 2010.
- M. F. P. T. Baldez Da Silva, B. S. Chagas, V. Guimarães et al., “HPV31 and HPV33 incidence in cervical samples from women in Recife, Brazil,” Genetics and Molecular Research, vol. 8, no. 4, pp. 1437–1443, 2009.
- B. S. Chagas, M. V. A. Batista, V. Guimarães, V. Q. Balbino, S. Crovella, and A. C. Freitas, “New variants of E6 and E7 oncogenes of human papillomavirus type 31 identified in Northeastern Brazil,” Gynecologic Oncology, vol. 123, no. 2, pp. 284–288, 2011.
- M. R. Pillai, R. Hariharan, J. M. Babu et al., “Molecular variants of HPV-16 associated with cervical cancer in Indian population,” International Journal of Cancer, vol. 125, no. 1, pp. 91–103, 2009.
- T. R. Alencar, D. M. Cerqueira, M. R. D. Cruz, P. S. Wyant, E. D. Ramalho, and C. R. F. Martins, “New HPV-16 European and non-European variants in Central Brazil,” Virus Genes, vol. 35, no. 1, pp. 1–4, 2007.
- D. M. Cerqueira, T. Raiol, N. M. C. Véras et al., “New variants of human papillomavirus type 18 identified in central Brazil,” Virus Genes, vol. 37, no. 2, pp. 282–287, 2008.
- T. Raiol, P. S. Wyant, R. M. S. De Amorim et al., “Genetic variability and phylogeny of the high-risk HPV-31, -33, -35, -52, and -58 in Central Brazil,” Journal of Medical Virology, vol. 81, no. 4, pp. 685–692, 2009.
- M. M. Castro, I. P. Farias, C. M. Borborema-Santos, G. Correia, and S. Astolfi-Filho, “Prevalence of human papillomavirus (HPV) type 16 variants and rare HPV types in the central Amazon region.,” Genetics and Molecular Research, vol. 10, no. 1, pp. 186–196, 2011.
- S. Pande, N. Jain, B. K. Prusty et al., “Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in North India,” Journal of Clinical Microbiology, vol. 46, no. 3, pp. 1060–1066, 2008.
- I. E. Calleja-Macias, L. L. Villa, J. C. Prado et al., “Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16,” Journal of Virology, vol. 79, no. 21, pp. 13630–13640, 2005.
- I. E. Calleja-Macias, M. Kalantari, J. Huh et al., “Genomic diversity of human papillomavirus-16, 18, 31, and 35 isolates in a Mexican population and relationship to European, African, and Native American variants,” Virology, vol. 319, no. 2, pp. 315–323, 2004.
- G. Cornut, S. Gagnon, C. Hankins et al., “Polymorphism of the capsid L1 gene of human papillomavirus types 31, 33, and 35,” Journal of Medical Virology, vol. 82, no. 7, pp. 1168–1178, 2010.
- H. Arias-Pulido, C. L. Peyton, N. Torrez-Martínez, D. N. Anderson, and C. M. Wheeler, “Human papillomavirus type 18 variant lineages in United States populations characterized by sequence analysis of LCR-E6, E2, and L1regions,” Virology, vol. 338, no. 1, pp. 22–34, 2005.
- J. C. Prado, I. E. Calleja-Macias, H. U. Bernard et al., “Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18,” Virology, vol. 340, no. 1, pp. 95–104, 2005.
- V. Cento, N. Rahmatalla, M. Ciccozzi, A. Lo Presti, C. F. Perno, and M. Ciotti, “Human Papillomaviruses 53 and 66: clinical aspects and genetic analysis,” Virus Research, vol. 163, no. 1, pp. 212–222, 2012.
- F. Karlsen, M. Kalantari, A. Jenkins et al., “Use of multiple PCR primer sets for optimal detection of human papillomavirus,” Journal of Clinical Microbiology, vol. 34, no. 9, pp. 2095–2100, 1996.
- R. Staden, “The staden sequence analysis package,” Applied Biochemistry and Biotechnology B, vol. 5, no. 3, pp. 233–241, 1996.
- K. Tamura, D. Peterson, N. Peterson, G. Stecher, M. Nei, and S. Kumar, “MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods,” Molecular Biologica Land Evolution, vol. 28, no. 10, pp. 2731–2739, 2011.
- S. Saha and G. P. S. Raghava, “BcePred: prediction of continuous B-cell epitopes in antigenic sequences using physico-chemical properties,” in Proceedings of the 3rd International Conference on Artificial Immune Systems (ICARIS '04), G. Nicosia, V. Cutello, P. J. Bentley, and J. Timis, Eds., vol. 3239 of LNCS, pp. 197–204, Springer, 2004.
- H. Singh and G. P. S. Raghava, “ProPred1: prediction of promiscuous MHC Class-I binding sites,” Bioinformatics, vol. 19, no. 8, pp. 1009–1014, 2003.
- H. Singh and G. P. Raghava, “ProPred: prediction of HLA-DR binding sites,” Bioinformatics, vol. 17, no. 12, pp. 1236–1237, 2001.
- D. Geraets, L. Alemany, N. Guimera et al., “Detection of rare and possibly carcinogenic Human Papillomavirus genotypes as single infections in invasive cervical cancer,” The Journal of Pathology, vol. 228, no. 4, pp. 534–543, 2012.
- L. Fu, K. van Doorslaer, Z. Chen et al., “Degradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity,” PLoS ONE, vol. 5, no. 9, Article ID e12816, pp. 1–8, 2010.
- T. Mesplède, D. Gagnon, F. Bergeron-Labrecque et al., “p53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes,” Journal of Virology, vol. 86, no. 1, pp. 94–107, 2012.